The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA
Open accessAbstract
Polymer and lipid nanoparticles have been extensively used as carriers to address the biological barriers encountered in siRNA and mRNA delivery. In this review, we summarize the critical role of nanoparticle’s charges and ionizability in complexing RNAs, binding biological components, escaping from the endosome, and releasing RNAs to the cytoplasm. We highlight the significant impact of the apparent pKa of nanoparticles on the efficacy and toxicity of the nanoparticles and the importance of optimizing pKa in the development of lead formulations for RNAs. Also, we discuss the feasibility of fine-tuning of pKa in nanoparticles and the applications of using this approach in the optimization of delivery systems for RNAs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticles: Properties, applications and toxicities
Khan, I., Saeed, K., & Khan, I. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2017.05.011 · Cited by 6,244
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · cited 1×
“Compared to conventional vaccines, it is much faster to develop mRNA-based vaccines, allowing us to promptly respond to virus outbreaks [4,51].”
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 2×
“It is generally believed that the structural and physicochemical properties of nanoparticles play important roles in delivering RNAs [8,21,35,47,67].”
InfluentialSystemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,337
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948
Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines
Hassett, K. J., Benenato, K. E., Jacquinet, E., Lee, A., Woods, A., Yuzhakov, O., Himansu, S., Deterling, J., Geilich, B. M., Ketova, T., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.013 · Cited by 927
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796
Kulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663 · cited 1×
“LNPs are composed of a mixture of ionizable or cationic lipid, phospholipid, polyethylene glycol (PEG)-lipid, and cholesterol [39].”
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Billingsley, M. M., Singh, N., Ravikumar, P., Zhang, R., June, C. H., & Mitchell, M. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04246 · Cited by 636
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615
Patisiran: First Global Approval
Hoy, S. M. (2018) · Drugs · doi:10.1007/s40265-018-0983-6 · Cited by 614
Lipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584 · cited 1×
“After entering the cells, mRNAs express encoded proteins to produce a rapid but transient therapeutic effect [4]. mRNA-based therapies have been investigated in clinical trials as cancer therapies, treatments for genetic diseases, protein replacement therapies, and vaccines [5].”
Zhou, K., Wang, Y., Huang, X., Luby‐Phelps, K., Sumer, B. D., & Gao, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100884 · Cited by 573
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R., & van der Meel, R. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00368 · Cited by 527
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322937111 · Cited by 488
Protonation constants of chitosan with different molecular weight and degree of deacetylation
Wang, Q. Z., Chen, X. G., Liu, N., Wang, S. X., Liu, C. S., Meng, X. H., & Liu, C. G. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.01.001 · Cited by 486
Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
Maugeri, M., Nawaz, M., Papadimitriou, A., Angerfors, A., Camponeschi, A., Na, M., Hölttä, M., Skantze, P., Johansson, S., Sundqvist, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12275-6 · Cited by 428
Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414
Overcoming Endosomal Entrapment in Drug Delivery
Pei, D., & Buyanova, M. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00778 · Cited by 402
Brief update on endocytosis of nanomedicines
Patel, S., Kim, J., Herrera, M., Mukherjee, A., Kabanov, A. V., & Sahay, G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.004 · Cited by 400
Recent Advances in Chitosan-Based Carriers for Gene Delivery
Cao, Y., Tan, Y. F., Wong, Y. S., Liew, M. W. J., & Venkatraman, S. (2019) · Marine Drugs · doi:10.3390/md17060381 · Cited by 361
Hajj, K. A., Ball, R. L., Deluty, S. B., Singh, S. R., Strelkova, D., Knapp, C. M., & Whitehead, K. A. (2019) · Small · doi:10.1002/smll.201805097 · Cited by 312
Ultra-pH-Sensitive Nanoprobe Library with Broad pH Tunability and Fluorescence Emissions
Ma, X., Wang, Y., Zhao, T., Li, Y., Su, L.-C., Wang, Z., Huang, G., Sumer, B. D., & Gao, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5053158 · Cited by 292
McKinlay, C. J., Vargas, J. R., Blake, T. R., Hardy, J. W., Kanada, M., Contag, C. H., Wender, P. A., & Waymouth, R. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614193114 · Cited by 288
Tsui, F. C., Ojcius, D. M., & Hubbell, W. L. (1986) · Biophysical Journal · doi:10.1016/s0006-3495(86)83655-4 · Cited by 258
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
Fenton, O. S., Kauffman, K. J., McClellan, R. L., Appel, E. A., Dorkin, J. R., Tibbitt, M. W., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2016) · Advanced Materials · doi:10.1002/adma.201505822 · Cited by 252
Xu, X., Wu, J., Liu, Y., Yu, M., Zhao, L., Zhu, X., Bhasin, S., Li, Q., Ha, E., Shi, J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601273 · Cited by 250
Recent Development of pH-Responsive Polymers for Cancer Nanomedicine
Tang, H., Zhao, W., Yu, J., Li, Y., & Zhao, C. (2018) · Molecules · doi:10.3390/molecules24010004 · Cited by 239
How and Why Nanoparticle’s Curvature Regulates the Apparent pKa of the Coating Ligands
Wang, D., Nap, R. J., Lagzi, I., Kowalczyk, B., Han, S., Grzybowski, B. A., & Szleifer, I. G. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108154a · Cited by 236
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez-Gascón, A., Solinís, M. Á., & del Pozo-Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 223
Uchida, H., Miyata, K., Oba, M., Ishii, T., Suma, T., Itaka, K., Nishiyama, N., & Kataoka, K. (2011) · Journal of the American Chemical Society · doi:10.1021/ja204466y · Cited by 212
Endosomal Size and Membrane Leakiness Influence Proton Sponge-Based Rupture of Endosomal Vesicles
Vermeulen, L. M. P., Brans, T., Samal, S. K., Dubruel, P., Demeester, J., De Smedt, S. C., Remaut, K., & Braeckmans, K. (2018) · ACS Nano · doi:10.1021/acsnano.7b07583 · Cited by 212
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
Ramishetti, S., Hazan‐Halevy, I., Palakuri, R., Chatterjee, S., Naidu Gonna, S., Dammes, N., Freilich, I., Kolik Shmuel, L., Danino, D., & Peer, D. (2020) · Advanced Materials · doi:10.1002/adma.201906128 · Cited by 211
Gujrati, M., Malamas, A., Shin, T., Jin, E., Sun, Y., & Lu, Z.-R. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400787s · Cited by 206
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
Alabi, C. A., Love, K. T., Sahay, G., Yin, H., Luly, K. M., Langer, R., & Anderson, D. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306529110 · Cited by 188
Song, Y., Tang, C., & Yin, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.017 · Cited by 188
Fromen, C. A., Rahhal, T. B., Robbins, G. R., Kai, M. P., Shen, T. W., Luft, J. C., & DeSimone, J. M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.11.002 · Cited by 182
RNA therapy: Are we using the right molecules?
Yu, A.-M., Jian, C., Yu, A. H., & Tu, M.-J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.011 · Cited by 163
Uchida, S., Kinoh, H., Ishii, T., Matsui, A., Tockary, T. A., Takeda, K. M., Uchida, H., Osada, K., Itaka, K., & Kataoka, K. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.031 · Cited by 153
Chemical and structural modifications of RNAi therapeutics
Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K., & Kim, S. H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.015 · Cited by 147
In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle
Uchida, S., Itaka, K., Uchida, H., Hayakawa, K., Ogata, T., Ishii, T., Fukushima, S., Osada, K., & Kataoka, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056220 · Cited by 141
The Effect of Size and Shape of RNA Nanoparticles on Biodistribution
Jasinski, D. L., Li, H., & Guo, P. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.018 · Cited by 140
mRNA therapeutics deliver a hopeful message
Zhong, Z., Cafferty, S. M., Combes, F., Huysmans, H., Temmerman, J. D., Gitsels, A., Vanrompay, D. C. G., Catani, J. P., & Sanders, N. N. (2018) · Nano Today · doi:10.1016/j.nantod.2018.10.005 · Cited by 133
Kwon, Y. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200241v · Cited by 127
Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs
Johannes, L., & Lucchino, M. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0716 · Cited by 110
Polymeric siRNA gene delivery – transfection efficiency versus cytotoxicity
Kargaard, A., Sluijter, J. P. G., & Klumperman, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.046 · Cited by 101
Zhang, J., Fan, H., Levorse, D. A., & Crocker, L. S. (2011) · Langmuir · doi:10.1021/la104590k · Cited by 96
Sato, Y., Hatakeyama, H., Hyodo, M., & Harashima, H. (2015) · Molecular Therapy · doi:10.1038/mt.2015.222 · Cited by 88
Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function
Ramezanpour, M., Schmidt, M. L., Bodnariuc, I., Kulkarni, J. A., Leung, S. S. W., Cullis, P. R., Thewalt, J. L., & Tieleman, D. P. (2019) · Nanoscale · doi:10.1039/c9nr02297j · Cited by 88
Endocytosis in proliferating, quiescent and terminally differentiated cells
Hinze, C., & Boucrot, E. (2018) · Journal of Cell Science · doi:10.1242/jcs.216804 · Cited by 85
Suma, T., Miyata, K., Ishii, T., Uchida, S., Uchida, H., Itaka, K., Nishiyama, N., & Kataoka, K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.022 · Cited by 79
Non-covalent interactions in controlling pH-responsive behaviors of self-assembled nanosystems
Li, Y., Wang, Z., Wei, Q., Luo, M., Huang, G., Sumer, B. D., & Gao, J. (2016) · Polymer Chemistry · doi:10.1039/c6py01104g · Cited by 77
Recent advances in polymeric materials for the delivery of RNA therapeutics
Ulkoski, D., Bak, A., Wilson, J. T., & Krishnamurthy, V. R. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1663822 · Cited by 74
Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
Tang, X., Zhang, S., Fu, R., Zhang, L., Huang, K., Peng, H., Dai, L., & Chen, Q. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01208 · Cited by 69
Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors
Molinaro, R., Wolfram, J., Federico, C., Cilurzo, F., Marzio, L. D., Ventura, C. A., Carafa, M., Celia, C., & Fresta, M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.840286 · Cited by 69
Yamamoto, N., Sato, Y., Munakata, T., Kakuni, M., Tateno, C., Sanada, T., Hirata, Y., Murakami, S., Tanaka, Y., Chayama, K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.014 · Cited by 67
Shobaki, N., Sato, Y., & Harashima, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s188016 · Cited by 67
Schönherr, D., Wollatz, U., Haznar-Garbacz, D., Hanke, U., Box, K. J., Taylor, R. J., Ruiz, R., Beato, S., Becker, D., & Weitschies, W. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.028 · Cited by 65
Chitosan-based nanoparticles for in vivo delivery of interfering agents including siRNA
Vauthier, C., Zandanel, C., & Ramon, A. L. (2013) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2013.06.005 · Cited by 65
Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing
Wu, C., Li, J., Wang, W., & Hammond, P. (2018) · ACS Nano · doi:10.1021/acsnano.7b08777 · Cited by 61
Du, L., Wang, C., Meng, L., Cheng, Q., Zhou, J., Wang, X., Zhao, D., Zhang, J., Deng, L., Liang, Z., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.046 · Cited by 56
Titze-de-Almeida, S. S., Brandão, P. R. D. P., Faber, I., & Titze‐de‐Almeida, R. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00434-w · Cited by 52
Synthesis, Characterization, and Evaluation of Ionizable Lysine-Based Lipids for siRNA Delivery
Walsh, C. L., Nguyen, J., Tiffany, M. R., & Szoka, F. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300346h · Cited by 51
Zhao, Z., Li, Y., Shukla, R., Liu, H., Jain, A., Barve, A. J., & Cheng, K. (2019) · Theranostics · doi:10.7150/thno.34314 · Cited by 47
Self-citationSoliman, O. Y., Alameh, M., Cresenzo, G. D., Buschmann, M. D., & Lavertu, M. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.12.020 · Cited by 42
Property-Driven Design and Development of Lipids for Efficient Delivery of siRNA
Rajappan, K., Tanis, S. P., Mukthavaram, R., Roberts, S., Nguyen, M., Tachikawa, K., Sagi, A., Sablad, M., Limphong, P., Leu, A. I., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01407 · Cited by 38
Noncovalent tagging of siRNA with steroids for transmembrane delivery
Tai, W., & Gao, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.007 · Cited by 34
Djemaa, S. B., Munnier, E., Chourpa, I., Allard-Vannier, É., & David, S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.06.023 · Cited by 25
Polypeptide-Nanoparticle Interactions and Corona Formation Investigated by Monte Carlo Simulations
Carnal, F., Clavier, A., & Stoll, S. (2016) · Polymers · doi:10.3390/polym8060203 · Cited by 22
Biological and Therapeutic Applications of Small RNAs
Cheng, K., & Mahato, R. I. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0609-0 · Cited by 14
Self-citation
Cited by
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Hald Albertsen, C., Kulkarni, J. A., Witzigmann, D., Lind, M., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,185
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Zong, Y., Lin, Y., Wei, T., & Cheng, Q. (2023) · Advanced Materials · doi:10.1002/adma.202303261 · Cited by 477
Suzuki, Y., & Ishihara, H. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100424 · Cited by 298
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Zhang, L., More, K. R., Ojha, A., Jackson, C. B., Quinlan, B. D., Li, H., He, W., Farzan, M., Pardi, N., & Choe, H. (2023) · npj Vaccines · doi:10.1038/s41541-023-00751-6 · Cited by 244
Metadata
- Authors
- Patel, P., Ibrahim, N. M., & Cheng, K.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 42
- Issue
- 6
- Pages
- 448-460
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W3153698244
- Cited by
- 280
- References
- 86
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.